134 related articles for article (PubMed ID: 26260238)
21. Characterization of the Vibrio parahaemolyticus Na+/Glucose cotransporter. A bacterial member of the sodium/glucose transporter (SGLT) family.
Xie Z; Turk E; Wright EM
J Biol Chem; 2000 Aug; 275(34):25959-64. PubMed ID: 10852908
[TBL] [Abstract][Full Text] [Related]
22. SLC5 and SLC2 transporters in epithelia-cellular role and molecular mechanisms.
Raja M; Puntheeranurak T; Hinterdorfer P; Kinne R
Curr Top Membr; 2012; 70():29-76. PubMed ID: 23177983
[TBL] [Abstract][Full Text] [Related]
23. Conserved tyrosine in the first transmembrane segment of solute:sodium symporters is involved in Na+-coupled substrate co-transport.
Mazier S; Quick M; Shi L
J Biol Chem; 2011 Aug; 286(33):29347-29355. PubMed ID: 21705334
[TBL] [Abstract][Full Text] [Related]
24. Identification of phlorizin binding domains in sodium-glucose cotransporter family: SGLT1 as a unique model system.
Raja M; Kinne RK
Biochimie; 2015 Aug; 115():187-93. PubMed ID: 26086341
[TBL] [Abstract][Full Text] [Related]
25. Applications of thiyl radical cyclizations for the synthesis of thiosugars.
Malone A; Scanlan EM
Org Lett; 2013 Feb; 15(3):504-7. PubMed ID: 23330717
[TBL] [Abstract][Full Text] [Related]
26. Development of sodium glucose co-transporter 2 (SGLT2) inhibitors with novel structure by molecular docking and dynamics simulation.
Feng R; Dong L; Wang L; Xu Y; Lu H; Zhang J
J Mol Model; 2019 Jun; 25(6):175. PubMed ID: 31154518
[TBL] [Abstract][Full Text] [Related]
27. Structural biology: It's not all in the family.
Kanner BI
Nature; 2008 Jul; 454(7204):593-4. PubMed ID: 18668099
[No Abstract] [Full Text] [Related]
28. Ligand-induced differences in secondary structure of the Vibrio parahaemolyticus Na+/galactose cotransporter.
le Coutre J; Turk E; Kaback HR; Wright EM
Biochemistry; 2002 Jun; 41(25):8082-6. PubMed ID: 12069600
[TBL] [Abstract][Full Text] [Related]
29. Structural insights into genetic variants of Na(+)/glucose cotransporter SGLT1 causing glucose-galactose malabsorption: vSGLT as a model structure.
Raja M; Kinne RK
Cell Biochem Biophys; 2012 Jun; 63(2):151-8. PubMed ID: 22383112
[TBL] [Abstract][Full Text] [Related]
30. Properties of a Na+/galactose (glucose) symport system in Vibrio parahaemolyticus.
Sarker RI; Ogawa W; Tsuda M; Tanaka S; Tsuchiya T
Biochim Biophys Acta; 1996 Mar; 1279(2):149-56. PubMed ID: 8603081
[TBL] [Abstract][Full Text] [Related]
31. N-Glucosides as human sodium-dependent glucose cotransporter 2 (hSGLT2) inhibitors.
Yamamoto Y; Kawanishi E; Koga Y; Sakamaki S; Sakamoto T; Ueta K; Matsushita Y; Kuriyama C; Tsuda-Tsukimoto M; Nomura S
Bioorg Med Chem Lett; 2013 Oct; 23(20):5641-5. PubMed ID: 23999047
[TBL] [Abstract][Full Text] [Related]
32. Insight into the dynamic interaction of different carbohydrates with human surfactant protein D: molecular dynamics simulations.
Zhang J; Zheng Q; Zhang H
J Phys Chem B; 2010 Jun; 114(21):7383-90. PubMed ID: 20450150
[TBL] [Abstract][Full Text] [Related]
33. Molecular Aspects of
Ohkura K; Tabata A
Anticancer Res; 2023 Aug; 43(8):3747-3754. PubMed ID: 37500162
[TBL] [Abstract][Full Text] [Related]
34. Functional asymmetry of the human Na+/glucose transporter (hSGLT1) in bacterial membrane vesicles.
Quick M; Tomasevic J; Wright EM
Biochemistry; 2003 Aug; 42(30):9147-52. PubMed ID: 12885248
[TBL] [Abstract][Full Text] [Related]
35. Insights on Na(+) binding and conformational dynamics in multidrug and toxic compound extrusion transporter NorM.
Song J; Ji C; Zhang JZ
Proteins; 2014 Feb; 82(2):240-9. PubMed ID: 23873591
[TBL] [Abstract][Full Text] [Related]
36. Ion binding and internal hydration in the multidrug resistance secondary active transporter NorM investigated by molecular dynamics simulations.
Vanni S; Campomanes P; Marcia M; Rothlisberger U
Biochemistry; 2012 Feb; 51(6):1281-7. PubMed ID: 22295886
[TBL] [Abstract][Full Text] [Related]
37. [Thiosugars used as drugs].
Sarnik J; Czubatka-Bieńkowska A; Dziadek J; Witczak ZJ; Popławski T
Postepy Biochem; 2016; 62(4):526-534. PubMed ID: 28132455
[TBL] [Abstract][Full Text] [Related]
38. Development of a novel non-radioactive cell-based method for the screening of SGLT1 and SGLT2 inhibitors using 1-NBDG.
Chang HC; Yang SF; Huang CC; Lin TS; Liang PH; Lin CJ; Hsu LC
Mol Biosyst; 2013 Aug; 9(8):2010-20. PubMed ID: 23657801
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of novel C-aryl d-glucofuranosides as sodium-dependent glucose co-transporter 2 inhibitors.
Lin TS; Liw YW; Song JS; Hsieh TC; Yeh HW; Hsu LC; Lin CJ; Wu SH; Liang PH
Bioorg Med Chem; 2013 Nov; 21(21):6282-91. PubMed ID: 24071445
[TBL] [Abstract][Full Text] [Related]
40. SGLT inhibitors as new therapeutic tools in the treatment of diabetes.
Kinne RK; Castaneda F
Handb Exp Pharmacol; 2011; (203):105-26. PubMed ID: 21484569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
